GlassScriptPhysician profile
Yafell Serulle
NPI 1083932214
$51,967.57
in general payments reported to CMS, 2019-2025
22 companies · $11K in 2025
The $11K reported for 2025 was more than what 86% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,322 · 2020: $4,040 · 2021: $5,007 · 2022: $4,652 · 2023: $13K · 2024: $9,223 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,200 · Travel and Lodging: $5,319 · Food and Beverage: $3,641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,787.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,200.00 |
| Travel and Lodging | $5,318.66 |
| Food and Beverage | $3,640.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $26,008.53 | 2019-2025 | Penumbra System, Red 72, Smart Coil |
| Boston Scientific Corporation | $17,007.94 | 2024-2025 | Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial), Therasphere Administration Set, Embold Fibered |
| Stryker Corporation | $1,324.82 | 2019-2024 | Target |
| Medical Device Business Services, INC. | $1,080.88 | 2022 | |
| Relievant Medsystems, INC. | $1,074.65 | 2020-2022 | |
| Imperative Care, INC | $1,012.74 | 2022-2025 | Zoom Reperfusion Catheter |
| Microvention, INC. | $1,012.63 | 2024-2025 | Stent, Web Aneurysm Embolization System, Azur Cx Detachable |
| Medtronic, INC. | $826.13 | 2021-2025 | Kyphon Express II Kyphopak Tray, Pipeline, Osteocool Rf Ablation System |
| Balt USA, LLC | $468.11 | 2020-2025 | Eclipse 2l |
| Viz.Ai, INC. | $403.07 | 2022 | |
| Depuy Synthes Sales INC. | $265.43 | 2023-2024 | Embotrap, Trufill, Cerepak Uniform |
| Longeviti Neuro Solutions INC | $261.65 | 2021 | |
| Medtronic USA, INC. | $202.03 | 2020 | |
| Cardiva Medical, INC. | $187.43 | 2023-2025 | Cardiva Vascade 5f Vcs |
| Phenox INC. | $175.00 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Asahi Intecc Co., LTD. | $172.08 | 2025 | Asahi Neurovascular Guide Wire |
| Qapel Medical INC | $144.26 | 2025 | |
| Inspiremd LTD | $139.32 | 2025 | Cguard Prime Carotid Stent System |
| Rapid Medical LTD | $122.00 | 2022 | |
| Jazz Pharmaceuticals INC. | $32.57 | 2025 | |
| Integra Lifesciences Corporation | $31.98 | 2025 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Hakim |
| Terumo Medical Corporation | $14.32 | 2025 | R2p Misago |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yafell Serulle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.